Showing results (1261-1270 of 1,300) with videos related to

Sort By:
Pageof 130
Schizophrenia Research|January 15, 2017
Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national studyJack J Blanchard, Kristen R Bradshaw, Cristina P Garcia, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
A Multivariate Genomic Investigation of the Externalizing Spectrum and Suicide RiskPeter B Barr, Mallory Stephenson, Holly E Poore, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2025
Beyond symptom improvement: transdiagnostic and disorder-specific ways to assess functional and quality of life outcomes across mental disorders in adultsChristoph U Correll, Samuele Cortese, Marco Solmi, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program CohortPeter B Barr, Tim B Bigdeli, Jacquelyn L Meyers, et al.
Archives of General Psychiatry|June 6, 2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE TrialRichard S E Keefe, Robert M Bilder, Sonia M Davis, et al.
Journal of Neurotrauma|January 30, 2021
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical TrialOlga Brawman-Mintzer, X Charlene Tang, Marcel Bizien, et al.
JAMA Psychiatry|November 8, 2023
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program CohortPeter B Barr, Tim B Bigdeli, Jacquelyn L Meyers, et al.
Genetics|September 3, 1999
An exploration of the sequence of a 2.9-Mb region of the genome of Drosophila melanogaster: the Adh regionM Ashburner, S Misra, J Roote, et al.
The Lancet. Psychiatry|November 13, 2025
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trialsRichard S E Keefe, Philip D Harvey, Christoph U Correll, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertensionMona Alotaibi, Lloyd D Harvey, William C Nichols, et al.
Pageof 130